Integra Lifesciences Holdings Corp (IART)
22.99
+0.06
(+0.26%)
USD |
NASDAQ |
Nov 21, 16:00
22.99
0.00 (0.00%)
After-Hours: 20:00
Integra Lifesciences Holdings Enterprise Value: 3.298B for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 3.298B |
| November 19, 2024 | 3.294B |
| November 18, 2024 | 3.264B |
| November 15, 2024 | 3.294B |
| November 14, 2024 | 3.325B |
| November 13, 2024 | 3.328B |
| November 12, 2024 | 3.443B |
| November 11, 2024 | 3.493B |
| November 08, 2024 | 3.441B |
| November 07, 2024 | 3.497B |
| November 06, 2024 | 3.589B |
| November 05, 2024 | 3.451B |
| November 04, 2024 | 3.390B |
| November 01, 2024 | 3.017B |
| October 31, 2024 | 2.976B |
| October 30, 2024 | 3.032B |
| October 29, 2024 | 3.033B |
| October 28, 2024 | 3.019B |
| October 25, 2024 | 2.991B |
| October 24, 2024 | 2.985B |
| October 23, 2024 | 3.003B |
| October 22, 2024 | 3.009B |
| October 21, 2024 | 3.034B |
| October 18, 2024 | 3.062B |
| October 17, 2024 | 3.053B |
| Date | Value |
|---|---|
| October 16, 2024 | 3.056B |
| October 15, 2024 | 3.034B |
| October 14, 2024 | 3.012B |
| October 11, 2024 | 3.012B |
| October 10, 2024 | 3.015B |
| October 09, 2024 | 2.925B |
| October 08, 2024 | 2.878B |
| October 07, 2024 | 2.873B |
| October 04, 2024 | 2.840B |
| October 03, 2024 | 2.836B |
| October 02, 2024 | 2.865B |
| October 01, 2024 | 2.879B |
| September 30, 2024 | 2.931B |
| September 27, 2024 | 2.915B |
| September 26, 2024 | 2.884B |
| September 25, 2024 | 2.858B |
| September 24, 2024 | 2.916B |
| September 23, 2024 | 2.889B |
| September 20, 2024 | 2.878B |
| September 19, 2024 | 2.884B |
| September 18, 2024 | 2.888B |
| September 17, 2024 | 2.860B |
| September 16, 2024 | 2.872B |
| September 13, 2024 | 2.884B |
| September 12, 2024 | 2.898B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.836B
Minimum
Oct 03 2024
7.711B
Maximum
Apr 27 2021
5.415B
Average
5.492B
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 141.52B |
| Haemonetics Corp | 5.191B |
| ResMed Inc | 35.71B |
| Globus Medical Inc | 11.12B |
| Perspective Therapeutics Inc | 150.86M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.70M |
| Revenue (Quarterly) | 380.83M |
| Total Expenses (Quarterly) | 388.98M |
| EPS Diluted (Quarterly) | -0.14 |
| Gross Profit Margin (Quarterly) | 52.58% |
| Profit Margin (Quarterly) | -2.81% |
| Earnings Yield | -0.39% |
| Operating Earnings Yield | 1.62% |
| Normalized Earnings Yield | -0.3915 |